Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
March 4, 2019Comments Off on Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies Posted in: Insights
This article was originally published by Kiu Tay-Teo, PhD, André Ilbawi, MD, and Suzanne R. Hill, PhD in JAMA Netw Open. 2019;2(1):e186875. under the terms of the CC-BY License. Key Points Question How does income from…
The post Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies appeared first on DrugPatentWatch - Make Better Decisions.